<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="tumors, and other pathologies, including migraine, urinary tract dysfunction, dry" exact="eye disease," post="and obesity. Hence, the modulation of the TRPM8 channel"/>
 <result pre="Single Nucleotide Polymorphisms SNPs in the TRPM8 encoding gene and" exact="migraine" post="processes, thus positioning TRPM8 as a potential novel target"/>
 <result pre="a potential novel target for this disabling condition [9,10]. Dry" exact="eye disease" post="(DED), a growing problem today, due to increased pollution"/>
 <result pre="shed light on the real role of these channels in" exact="cancer" post="malignancies. In addition to the above mentioned pathologic processes,"/>
 <result pre="mentioned pathologic processes, TRPM8 channels have also been implicated in" exact="irritable bowel syndrome" post="(SNP increased risks) [16], oropharyngeal dysphagia (OD) [17], and"/>
 <result pre="could be particularly useful in the prevention and treatment of" exact="dry eye syndrome" post="(DES), vaginal dryness, and burning mouth syndrome [34]. In"/>
 <result pre="cream containing only MPO (13, Figure 1) in patients with" exact="atopic dermatitis" post="(AD) in real-life settings. In this clinical study, MPO"/>
 <result pre="containing only MPO (13, Figure 1) in patients with atopic" exact="dermatitis" post="(AD) in real-life settings. In this clinical study, MPO"/>
 <result pre="levels, weight gain, or fat depot levels and treatments for" exact="metabolic syndrome," post="obesity, prediabetes, and type II diabetes. Other applications have"/>
 <result pre="applications have been claimed, such as treating hypercholesterolemia, hypertension, coronary" exact="heart disease," post="diabetic neuropathy and retinopathy, erectile dysfunction, kidney disease, and"/>
 <result pre="been claimed, such as treating hypercholesterolemia, hypertension, coronary heart disease," exact="diabetic neuropathy" post="and retinopathy, erectile dysfunction, kidney disease, and pancreatitis, among"/>
 <result pre="claimed, such as treating hypercholesterolemia, hypertension, coronary heart disease, diabetic" exact="neuropathy" post="and retinopathy, erectile dysfunction, kidney disease, and pancreatitis, among"/>
 <result pre="treating hypercholesterolemia, hypertension, coronary heart disease, diabetic neuropathy and retinopathy," exact="erectile dysfunction," post="kidney disease, and pancreatitis, among others. Several non-menthol derivatives"/>
 <result pre="the topical treatment of patients with mild forms of dry" exact="eye disease" post="(DED) (TR: ISRCTN24802609 and ISRCTN13359367) [50]. Treatment with a"/>
 <result pre="feedback was observed in human corneal epithelial cells [62], and" exact="cancer" post="cells, such as TRPM8 transfected U2osB2 osteosarcoma [63], WERI-Rb1"/>
 <result pre="cells [62], and cancer cells, such as TRPM8 transfected U2osB2" exact="osteosarcoma" post="[63], WERI-Rb1 retinoblastoma, and human uveal melanoma (UM 92-1)"/>
 <result pre="as TRPM8 transfected U2osB2 osteosarcoma [63], WERI-Rb1 retinoblastoma, and human" exact="uveal melanoma" post="(UM 92-1) [64]. The effects observed in these cells"/>
 <result pre="companies, as potential drugs for neuropathic pain, inflammation, migraine, and" exact="cancer" post="[24]. However, most antagonists described in the literature lack"/>
 <result pre="selectivities (1000:1), antiproliferative activity in a LNCap cell line of" exact="prostate cancer" post="(64.3% cellular growth inhibition after three days) and apoptotic"/>
 <result pre="(1000:1), antiproliferative activity in a LNCap cell line of prostate" exact="cancer" post="(64.3% cellular growth inhibition after three days) and apoptotic"/>
 <result pre="in rat models of tactile allodynia and the inflammatory mechanical" exact="hypersensitivity" post="[73]. The same company discovered that the linear urea"/>
 <result pre="was nominated as a clinical candidate for the treatment of" exact="migraine" post="(reached phase I human clinical assays, no news since"/>
 <result pre="be developed as clinical candidates in the treatment of pain" exact="hypersensitivity" post="that was associated with bladder disorders. Due to the"/>
 <result pre="(47, Figure 4) produce considerable antinociceptive effects in orofacial pain" exact="hypersensitivity" post="induced by formalin and in neuropathic pain [90]. In"/>
 <result pre="induced by the well-known AMTB antagonist (50, Figure 4) on" exact="breast cancer" post="cell lines was due to the inhibition of NaV"/>
 <result pre="by the well-known AMTB antagonist (50, Figure 4) on breast" exact="cancer" post="cell lines was due to the inhibition of NaV"/>
 <result pre="drug Riluzole (53, Figure 5), used in the treatment of" exact="amyotrophic lateral sclerosis," post="was able to block cold allodynia alterations and mitigate"/>
 <result pre="12.YangJ.M.WeiE.T.KimS.J.YoonK.C.TRPM8 Channels and Dry EyePharmaceuticals20181112510.3390/ph11040125 13.LiuZ.WuH.WeiZ.WangX.ShenP.WangS.WangA.ChenW.LuY.TRPM8: A potential target for" exact="cancer" post="treatmentJ. Cancer Res. Clin. Oncol.20161421871188110.1007/s00432-015-2112-126803314 14.Hantute-GhesquierA.HaustrateA.PrevarskayaN.Lehen’kyiV.TRPM family channels in"/>
 <result pre="effects of a cream containing menthoxypropanediol, a TRPM8 agonist, in" exact="atopic dermatitis" post="patientsJ. Eur. Acad. Dermatol. Venereol.201933e67e6910.1111/jdv.1519930067875 40.RoggenkampD.WorthmannA.-C.SulzbergerM.WenckH.StaebF.NeufangG.Menthoxypropanediol inhibits nerve growth"/>
 <result pre="of a cream containing menthoxypropanediol, a TRPM8 agonist, in atopic" exact="dermatitis" post="patientsJ. Eur. Acad. Dermatol. Venereol.201933e67e6910.1111/jdv.1519930067875 40.RoggenkampD.WorthmannA.-C.SulzbergerM.WenckH.StaebF.NeufangG.Menthoxypropanediol inhibits nerve growth"/>
 <result pre="regulation by thermosensitive transient receptor potential channels in etoposide-resistant WERI-Rb1" exact="retinoblastoma" post="cellsExp. Eye Res.20129415717310.1016/j.exer.2011.12.00222182671 64.WalcherL.BuddeC.BohmA.LjubojevicN.SchweigerM.W.WaydbrinkH.v.d.ReimersI.MerglerS.ReinachP.S.DhandapaniP.et al.TRPM8 Activation via 3-Iodothyronamine Blunts"/>
 <result pre="ChannelsJ. Neurosci.20193994996910.1523/JNEUROSCI.1726-18.201830545944 67.BasE.NazirogluM.NazirogluM.PeczeL.ADP-Ribose and oxidative stress activate TRPM8 channel in" exact="prostate cancer" post="and kidney cellsSci. Rep.20199410010.1038/s41598-018-37552-030858386 68.JanssensA.GeesM.TothB.I.GhoshD.MulierM.VennekensR.VriensJ.TalaveraK.VoetsT.Definition of two agonist types"/>
 <result pre="Neurosci.20193994996910.1523/JNEUROSCI.1726-18.201830545944 67.BasE.NazirogluM.NazirogluM.PeczeL.ADP-Ribose and oxidative stress activate TRPM8 channel in prostate" exact="cancer" post="and kidney cellsSci. Rep.20199410010.1038/s41598-018-37552-030858386 68.JanssensA.GeesM.TothB.I.GhoshD.MulierM.VennekensR.VriensJ.TalaveraK.VoetsT.Definition of two agonist types"/>
 <result pre="antagonist, is not effective in rat models of inflammatory mechanical" exact="hypersensitivity" post="and neuropathic tactile allodyniaNaunyn. Schmiedebergs. Arch. Pharmacol.201538846547610.1007/s00210-015-1090-925662185 74.HorneD.B.BiswasK.BrownJ.BartbergerM.D.ClarineJ.DavisC.D.GoreV.K.HarriedS.HornerM.KallerM.R.et al.Discovery"/>
 <result pre="Number WO 201721735121122017 93.YapaK.T.D.S.DeuisJ.PetersA.A.KennyP.A.Roberts-ThomsonS.J.VetterI.MonteithG.R.Assessment of the TRPM8 inhibitor AMTB in" exact="breast cancer" post="cells and its identification as an inhibitor of voltage"/>
 <result pre="WO 201721735121122017 93.YapaK.T.D.S.DeuisJ.PetersA.A.KennyP.A.Roberts-ThomsonS.J.VetterI.MonteithG.R.Assessment of the TRPM8 inhibitor AMTB in breast" exact="cancer" post="cells and its identification as an inhibitor of voltage"/>
 <result pre="110.ClemmensenC.JallS.KleinertM.QuartaC.GruberT.SachsS.FischerK.GrandlG.LoherD.Sanchez-QuantE.et al.Coordinated targeting of cold and nicotinic receptors synergistically improves" exact="obesity" post="and type 2 diabetesNat. Commun.20189430410.1038/s41467-018-06769-y30353008 111.AlcaldeI.Íñigo-PortuguésA.González-GonzálezO.AlmarazL.ArtimeE.Morenilla-PalaoC.GallarJ.VianaF.Merayo-LlovesJ.BelmonteC.Morphological and functional changes"/>
 <result pre="114.KhalilM.BabesA.LakraR.FörschS.ReehP.W.WirtzS.BeckerC.NeurathM.F.EngelM.A.Transient receptor potential melastatin 8 ion channel in macrophages modulates" exact="colitis" post="through a balance-shift in TNF-alpha and interleukin-10 productionMucosal Immunol.201691500151310.1038/mi.2016.1626982596"/>
</results>
